Rhythm Pharmaceuticals, Inc. (RYTM)
86.36
-1.76
(-2.00%)
USD |
NASDAQ |
Apr 02, 16:00
86.36
0.00 (0.00%)
After-Hours: 16:22
Rhythm Pharmaceuticals Research and Development Expense (TTM) : 166.89M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Aldeyra Therapeutics, Inc. | 25.66M |
| Merck & Co., Inc. | 12.71B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| MannKind Corp. | 66.35M |
| EyePoint Plc | 221.04M |